管家婆心水论坛 advises not to screen for cardiac disease in adults at low risk for coronary heart disease
Philadelphia, March 17, 2015 -- Physicians should not screen for cardiac disease in adults at low risk for coronary heart disease (CHD) with resting or stress electrocardiography, stress echocardiography, or stress myocardial perfusion imaging, the 管家婆心水论坛 (ACP) advises in a published today in Annals of Internal Medicine.
"Cardiac screening in adults at low risk for coronary heart disease is low value care because it does not improve patient outcomes and it can lead to potential harms," said Dr. David Fleming, president, ACP. "Physicians should instead focus on strategies for improving cardiovascular health by treating modifiable risk factors such as smoking, diabetes, hypertension, high cholesterol, obesity, and encouraging healthy levels of exercise."
Authored for ACP's High Value Care Task Force by Dr. Roger Chou, "Cardiac Screening with Electrocardiogram, Stress Echocardiography, or Myocardial Perfusion Imaging" aims to provide physicians with practical advice based on the best available evidence.
Although CHD the single leading cause of death in the United States, the benefits of cardiac screening in low-risk adults have long been questioned, Dr. Chou writes. Despite potential harms and insufficient evidence of benefits, cardiac screening tests are still frequently obtained in clinical practice -- and perhaps increasing. Electrocardiography is among the most commonly performed diagnostic tests in the United States.
The paper notes several factors that may contribute to inappropriate cardiac screening of low-risk adults, including patient expectations, commercial screening programs, financial incentives, concerns about malpractice liability, and overestimating the benefits and underestimating the harms of screening.
"The limited data suggest that even 'baseline' ECGs are rarely helpful," Dr. Fleming said. "It is easy to overlook false positives as potential harms, for example, but they may result in unnecessary tests and treatments with their own additional risks, and the harms of radiation exposure may not be seen for years."
Rather than screening low risk adults for CHD, physicians should start a cardiovascular risk assessment with a global risk score that combines individual risk factor measurements into a single quantitative estimate of risk. Patients in the low risk category should not be screened with resting or stress electrocardiography, stress echocardiography, or stress myocardial perfusion imaging.
ACP's advice does not pertain to patients with symptoms or to athletes for pre-participation screening.
A was also published in Annals.
About ACP's High Value Care Task Force
is designed to help doctors and patients
understand the benefits, harms, and costs of tests and treatment
options for common clinical issues so they can pursue care together
that improves health, avoids harms, and eliminates wasteful
practices. ACP defines High Value Care as the delivery of services
providing benefits that make their harms and costs worthwhile.
ACP's High Value Care Task Force papers focus on value by
evaluating the benefits, harms, and costs of a test or
intervention. Value is not merely cost. Some expensive tests and
treatments have high value because they provide high benefit and
low harm. Conversely, some inexpensive tests or treatments have low
value because they do not provide enough benefit to justify even
their low costs and might even be harmful.
About the 管家婆心水论坛
The 管家婆心水论坛 is the largest
medical specialty organization and the second-largest physician
group in the United States. ACP members include 141,000 internal
medicine physicians (internists), related subspecialists, and
medical students. Internal medicine physicians are specialists who
apply scientific knowledge and clinical expertise to the diagnosis,
treatment, and compassionate care of adults across the spectrum
from health to complex illness. Follow ACP on and .